Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

Casiraghi, 2011, Epstein–Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis, J. Neuroimmunol., 230, 173, 10.1016/j.jneuroim.2010.08.003 Correale, 2006, The risk of relapses in multiple sclerosis during systemic infections, Neurology, 67, 652, 10.1212/01.wnl.0000233834.09743.3b De Stefano, 1999, In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis, Brain, 122, 1933, 10.1093/brain/122.10.1933 Elong Ngono, 2012, Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing–remitting multiple sclerosis patients, Clin. Immunol., 144, 117, 10.1016/j.clim.2012.05.009 Filippi, 1998, Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis, Ann. Neurol., 43, 809, 10.1002/ana.410430616 Goodkin, 1998, A serial study of new MS lesions and the white matter from which they arise, Neurology, 51, 1689, 10.1212/WNL.51.6.1689 Hansen, 2009, Partial volume effect (PVE) on the arterial input function (AIF) in T1-weighted perfusion imaging and limitations of the multiplicative rescaling approach, Magn. Reson. Med., 62, 1055, 10.1002/mrm.22098 Harris, 1991, Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing–remitting multiple sclerosis: implications for clinical trials and natural history, Ann. Neurol., 29, 548, 10.1002/ana.410290515 Iannotti, 1987, Simplified, noninvasive PET measurement of blood–brain barrier permeability, J. Comput. Assist. Tomogr., 11, 390, 10.1097/00004728-198705000-00004 Ingrisch, 2012, Quantification of perfusion and permeability in multiple sclerosis, Investig. Radiol., 47, 252, 10.1097/RLI.0b013e31823bfc97 Kermode, 1990, Breakdown of the blood–brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications, Brain, 113, 1477, 10.1093/brain/113.5.1477 Kirk, 2003, Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination, J. Pathol., 201, 319, 10.1002/path.1434 Kraus, 2008, Interferon-beta stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro, Mult. Scler., 14, 843, 10.1177/1352458508088940 Larochelle, 2011, How do immune cells overcome the blood–brain barrier in multiple sclerosis?, FEBS Lett., 585, 3770, 10.1016/j.febslet.2011.04.066 Larsson, 2008, Dynamic contrast-enhanced quantitative perfusion measurement of the brain usingT1-weighted MRI at 3T, J. Magn. Reson. Imaging, 27, 754, 10.1002/jmri.21328 Larsson, 2009, Measurement of brain perfusion, blood volume, and blood–brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3Tesla, Magn. Reson. Med., 62, 1270, 10.1002/mrm.22136 Lassmann, 2012, Progressive multiple sclerosis: pathology and pathogenesis, Nat. Rev. Neurol., 8, 647, 10.1038/nrneurol.2012.168 Lund, 2013, Blood–brain barrier permeability of normal appearing white matter in relapsing–remitting multiple sclerosis, PLoS ONE, 8, e56375, 10.1371/journal.pone.0056375 Mancuso, 2010, Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis, J. Med. Virol., 82, 1051, 10.1002/jmv.21764 McQuaid, 2009, The effects of blood–brain barrier disruption on glial cell function in multiple sclerosis, Biochem. Soc. Trans., 37, 329, 10.1042/BST0370329 Minagar, 2003, Blood–brain barrier disruption in multiple sclerosis, Mult. Scler., 9, 540, 10.1191/1352458503ms965oa Owens, 2012, Trigger, pathogen, or bystander: the complex nexus linking Epstein–Barr virus and multiple sclerosis, Mult. Scler., 18, 1204, 10.1177/1352458512448109 Pakpoor, 2013, The risk of developing multiple sclerosis in individuals seronegative for Epstein–Barr virus: a meta-analysis, Mult. Scler., 19, 162, 10.1177/1352458512449682 Plumb, 2002, Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis, Brain Pathol., 12, 154, 10.1111/j.1750-3639.2002.tb00430.x Poser, 1986, Pathogenesis of multiple sclerosis. A critical reappraisal, Acta Neuropathol., 71, 1, 10.1007/BF00687954 Poser, 1992, Multiple sclerosis. Observations and reflections—a personal memoir, J. Neurol. Sci., 107, 127, 10.1016/0022-510X(92)90280-X Poser, 1994, The role of trauma in the pathogenesis of multiple sclerosis: a review, Clin. Neurol. Neurosurg., 96, 103, 10.1016/0303-8467(94)90042-6 Poser, 2004, Multiple sclerosis trait: the premorbid stage of multiple sclerosis. A hypothesis, Acta Neurol. Scand., 109, 239, 10.1111/j.1600-0404.2004.00277.x Runge, 1985, Initial clinical evaluation of gadolinium DTPA for contrast-enhanced magnetic resonance imaging, Magn. Reson. Imaging, 3, 27, 10.1016/0730-725X(85)90006-2 Schumacher, 1965, Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis, Ann. N. Y. Acad. Sci., 122, 552, 10.1111/j.1749-6632.1965.tb20235.x Silver, 2001, Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood–brain barrier integrity in multiple sclerosis: a preliminary study, Mult. Scler., 7, 75, 10.1177/135245850100700201 Soon, 2007, A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis, J. Neurol., 254, 306, 10.1007/s00415-006-0356-z Tofts, 1995, Optimal detection of blood–brain barrier defects with Gd-DTPA MRI-the influences of delayed imaging and optimised repetition time, Magn. Reson. Imaging, 14, 373, 10.1016/0730-725X(96)00023-9 van Osch, 2001, Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI, Magn. Reson. Med., 45, 477, 10.1002/1522-2594(200103)45:3<477::AID-MRM1063>3.0.CO;2-4 Vos, 2005, Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis, Neurobiol. Dis., 20, 953, 10.1016/j.nbd.2005.06.012 Werring, 2000, The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study, Brain, 123, 1667, 10.1093/brain/123.8.1667 Willis, 2009, Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain, Brain, 132, 3318, 10.1093/brain/awp200